Back to mobile site

More on ALKS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-103.8% Growth)
- Ratings (6.1 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ALKS Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 38.39M
Investments - short-term 162.93M
Receivables 22.97M
Inventory 20.43M
Prepaid expenses and other current assets 8.24M
Total current assets 252.96M
PROPERTY, PLANT AND EQUIPMENT, NET 95.02M
INVESTMENTS - LONG-TERM 93.41M
OTHER ASSETS 11.06M
TOTAL ASSETS 452.45M
Accounts payable and accrued expenses 44.93M
Deferred revenue - current 3.12M
Total current liabilities 48.06M
DEFERRED REVENUE - LONG-TERM 4.84M
OTHER LONG-TERM LIABILITIES 7.54M
Total liabilities 60.43M
COMMITMENTS AND CONTINGENCIES (Note 11)
SHAREHOLDERS' EQUITY:
Common stock 1.06M
Treasury stock, at cost (10,226,304 and 10,069,208 shares at June 30, 2011 and March 31, 2011, respectively) -131.1M
Additional paid-in capital 936.3M
Accumulated other comprehensive loss -3.01M
Accumulated deficit -411.23M
Total shareholders' equity 392.02M
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 452.45M
SHAREHOLDERS' EQUITY:
Common stock 4K